Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Citi
Baxter
QuintilesIMS
Covington
Accenture
Deloitte
McKinsey
Teva

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,791,127

« Back to Dashboard

Which drugs does patent 8,791,127 protect, and when does it expire?

Patent 8,791,127 protects SITAVIG and is included in one NDA.

This patent has twenty-seven patent family members in twenty-five countries.
Summary for Patent: 8,791,127
Title:Mucosal bioadhesive slow release carrier for delivering active principles
Abstract: A mucosal bioadhesive slow release carrier comprising an active principle and devoid of starch, lactose, which can release the active principal for a duration of longer than 20 hours. This bioadhesive carrier contains a diluent, an alkali metal alkylsulfate, a binding agent, at least one bioadhesive polymer and at least one sustained release polymer, as well as a method for its preparation.
Inventor(s): Costantini; Dominique (Paris, FR), Lemarchand; Caroline (Paris, FR)
Assignee: BioAlliance Pharma (Paris, FR)
Application Number:13/943,504
Patent Claim Types:
see list of patent claims
Formulation; Use;

Drugs Protected by US Patent 8,791,127

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Epi Hlth SITAVIG acyclovir TABLET;BUCCAL 203791-001 Apr 12, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y TREATMENT OF HERPES LABIALIS ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,791,127

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
06290480Mar 24, 2006

Non-Orange Book US Patents Family Members for Patent 8,791,127

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,211,466 Mucosal bioadhesive slow release carrier for delivering active principles ➤ Try a Free Trial
8,747,896 Mucosal bioadhesive slow release carrier for delivering active principles ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 8,791,127

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 060085 ➤ Try a Free Trial
Austria 446743 ➤ Try a Free Trial
Australia 2007231029 ➤ Try a Free Trial
Brazil PI0709057 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Farmers Insurance
Boehringer Ingelheim
Harvard Business School
Queensland Health
Daiichi Sankyo
Dow
US Army
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.